JP2017066161A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017066161A5 JP2017066161A5 JP2017000444A JP2017000444A JP2017066161A5 JP 2017066161 A5 JP2017066161 A5 JP 2017066161A5 JP 2017000444 A JP2017000444 A JP 2017000444A JP 2017000444 A JP2017000444 A JP 2017000444A JP 2017066161 A5 JP2017066161 A5 JP 2017066161A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administration
- subject
- expression
- increased
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 102000049320 CD36 Human genes 0.000 claims 2
- 108010045374 CD36 Antigens Proteins 0.000 claims 2
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000008595 infiltration Effects 0.000 claims 1
- 238000001764 infiltration Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
- 210000004925 microvascular endothelial cell Anatomy 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71817005P | 2005-09-16 | 2005-09-16 | |
| US60/718,170 | 2005-09-16 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015156656A Division JP6175107B2 (ja) | 2005-09-16 | 2015-08-07 | Ｃｄ３６の発現を減少させる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017066161A JP2017066161A (ja) | 2017-04-06 |
| JP2017066161A5 true JP2017066161A5 (cg-RX-API-DMAC7.html) | 2017-06-29 |
| JP6385476B2 JP6385476B2 (ja) | 2018-09-05 |
Family
ID=37889419
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008531412A Active JP5416971B2 (ja) | 2005-09-16 | 2006-09-18 | Ｃｄ３６の発現を減少させる方法 |
| JP2012181082A Active JP5805596B2 (ja) | 2005-09-16 | 2012-08-17 | Ｃｄ３６の発現を減少させる方法 |
| JP2013006199A Active JP5809649B2 (ja) | 2005-09-16 | 2013-01-17 | Ｃｄ３６の発現を減少させる方法 |
| JP2015115856A Active JP6157539B2 (ja) | 2005-09-16 | 2015-06-08 | Ｃｄ３６の発現を減少させる方法 |
| JP2015156656A Active JP6175107B2 (ja) | 2005-09-16 | 2015-08-07 | Ｃｄ３６の発現を減少させる方法 |
| JP2017000444A Active JP6385476B2 (ja) | 2005-09-16 | 2017-01-05 | Ｃｄ３６の発現を減少させる方法 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008531412A Active JP5416971B2 (ja) | 2005-09-16 | 2006-09-18 | Ｃｄ３６の発現を減少させる方法 |
| JP2012181082A Active JP5805596B2 (ja) | 2005-09-16 | 2012-08-17 | Ｃｄ３６の発現を減少させる方法 |
| JP2013006199A Active JP5809649B2 (ja) | 2005-09-16 | 2013-01-17 | Ｃｄ３６の発現を減少させる方法 |
| JP2015115856A Active JP6157539B2 (ja) | 2005-09-16 | 2015-06-08 | Ｃｄ３６の発現を減少させる方法 |
| JP2015156656A Active JP6175107B2 (ja) | 2005-09-16 | 2015-08-07 | Ｃｄ３６の発現を減少させる方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (10) | US7541340B2 (cg-RX-API-DMAC7.html) |
| EP (5) | EP3725324A1 (cg-RX-API-DMAC7.html) |
| JP (6) | JP5416971B2 (cg-RX-API-DMAC7.html) |
| KR (9) | KR101621493B1 (cg-RX-API-DMAC7.html) |
| CN (6) | CN101296704B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006292352B2 (cg-RX-API-DMAC7.html) |
| CA (8) | CA2947330C (cg-RX-API-DMAC7.html) |
| DK (1) | DK1931369T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1206971A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007035640A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1599216E (pt) | 2003-02-04 | 2013-12-17 | Cornell Res Foundation Inc | Métodos de prevenção da transição de permeabilidade mitocondrial |
| DK2604285T3 (en) | 2003-05-01 | 2014-12-01 | Cornell Res Foundation Inc | Method and carrier complex for delivering molecules to cells |
| CA2971931C (en) | 2004-01-23 | 2019-01-08 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| US7687243B1 (en) * | 2005-06-06 | 2010-03-30 | Crook Tonia M | Automated method for detecting apoptosis in cells |
| EP3725324A1 (en) | 2005-09-16 | 2020-10-21 | Cornell Research Foundation, Inc. | Aromatic-cationic peptide for use in a method for reducing cd36 expression |
| DK2252312T3 (da) * | 2008-02-07 | 2014-06-16 | Univ Cornell | Fremgangsmåder til forebyggelse eller behandling af insulinresistens |
| CN101951936A (zh) | 2008-02-26 | 2011-01-19 | 康奈尔大学 | 用于防止和治疗急性肾损伤的方法 |
| CN102573881A (zh) * | 2009-03-20 | 2012-07-11 | 通用医疗公司以马萨诸塞州通用医疗公司名义经营 | 预防和治疗烧伤损伤和继发性并发症的方法 |
| JP5909182B2 (ja) * | 2009-08-12 | 2016-04-26 | コーネル ユニヴァーシティー | 代謝性症候群を予防し又は治療するための方法 |
| EP3338788A1 (en) | 2009-08-24 | 2018-06-27 | Stealth Peptides International, Inc. | Methods and copositions for preventing or treating opthalmic conditions |
| CN102711785A (zh) * | 2009-10-05 | 2012-10-03 | 康奈尔大学 | 预防或治疗心力衰竭的方法 |
| EP3090754A1 (en) * | 2009-12-31 | 2016-11-09 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
| US20130190244A1 (en) * | 2009-12-31 | 2013-07-25 | Stealth Peptides International, Inc. | Methods for performing a coronary artery bypass graft procedure |
| CN103037901B (zh) * | 2010-06-01 | 2018-04-27 | 康奈尔大学 | 抑制cd36以控制肥胖和胰岛素敏感性 |
| US9345738B2 (en) * | 2010-07-09 | 2016-05-24 | Stealth Biotherapeutics Corp. | Methods for the prevention or treatment of no-reflow following ischemia/reperfusion injury |
| CA2865317A1 (en) * | 2012-02-22 | 2013-08-29 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
| CA2869080C (en) * | 2012-03-30 | 2020-09-01 | Stealth Peptides International, Inc. | Methods and compositions for the prevention and treatment neuropathy |
| JP2015529655A (ja) * | 2012-08-02 | 2015-10-08 | ステルス ペプチドズ インターナショナル インコーポレイテッド | アテローム性硬化症の処置方法 |
| PL2936151T3 (pl) * | 2012-12-18 | 2018-11-30 | Biocrine Ab | Sposoby leczenia i/lub ograniczania rozwoju cukrzycy |
| WO2014185952A1 (en) * | 2013-05-14 | 2014-11-20 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of left ventricle remodeling |
| CA2916492A1 (en) * | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
| US20160375088A1 (en) * | 2013-09-30 | 2016-12-29 | Brian Yinge ZHAO | Cardiolipin-targeted peptides inhibit beta-amyloid oligomer toxicity |
| US9895410B2 (en) * | 2013-12-12 | 2018-02-20 | Cornell University | Methods for preventing and treating oral cancers |
| WO2015095077A1 (en) * | 2013-12-16 | 2015-06-25 | Cornell University | Methods and compositions for treating and preventing cognitive dysfunction |
| CN107041946A (zh) * | 2017-03-24 | 2017-08-15 | 南京大学 | 化合物ss‑31在制备治疗动脉粥样硬化及相关疾病药物或制剂上的应用 |
| US11392555B2 (en) | 2019-05-15 | 2022-07-19 | Pure Storage, Inc. | Cloud-based file services |
| US20220288013A1 (en) * | 2019-07-26 | 2022-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | 1,8-cineol coated implants |
| JP2023503283A (ja) | 2019-11-20 | 2023-01-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 放射線治療の為の予防的な皮膚処置 |
| CN117881411A (zh) | 2021-06-01 | 2024-04-12 | 艾迪雅生物有限责任公司 | 用于眼部药物的延长释放药物递送系统和使用方法 |
| WO2025021993A1 (en) | 2023-07-27 | 2025-01-30 | Omnilinx Therapeutics Ag | Endocytic and scavenger receptor-targeting chimeric proteins and uses thereof |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5602100A (en) * | 1988-06-30 | 1997-02-11 | Astra Ab | Dermorphin analogs having pharmacological activity |
| US5312899A (en) * | 1988-06-30 | 1994-05-17 | Biochem Pharma, Inc. | Dermorphin analogs |
| US5674980A (en) * | 1989-12-21 | 1997-10-07 | Biogen Inc | Fusion protein comprising tat-derived transport moiety |
| US5858784A (en) * | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5674534A (en) * | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
| ATE255450T1 (de) * | 1995-06-09 | 2003-12-15 | Hisamitsu Pharmaceutical Co | Matrix für iontophorese |
| US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| FR2756284B1 (fr) * | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5885958A (en) * | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| EP1037911A4 (en) * | 1997-12-10 | 2003-07-23 | Univ Washington | ANTI-PATHOGEN SYSTEM AND METHOD FOR USE THEREOF |
| AU3965699A (en) * | 1998-04-24 | 1999-11-16 | Mitokor | Compounds and methods for treating mitochondria-associated diseases |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| SE9900961D0 (sv) | 1999-03-16 | 1999-03-16 | Astra Ab | Novel compounds |
| WO2001025486A1 (en) * | 1999-10-04 | 2001-04-12 | University Of Medicine And Dentistry Of New Jersey | Methods for identifying rna binding compounds |
| US6759520B1 (en) * | 1999-10-28 | 2004-07-06 | The New England Medical Center Hospitals, Inc. | Chimeric analgesic peptides |
| US20050192215A1 (en) * | 2000-01-21 | 2005-09-01 | Malabika Ghosh | Methods and materials relating to novel polypeptides and polynucleotides |
| EP1303186B1 (en) | 2000-07-18 | 2011-01-26 | Cornell Research Foundation, Inc. | Medicinal uses of mu-opioid receptor agonists |
| US6900178B2 (en) * | 2000-09-12 | 2005-05-31 | University Of Kentucky Research Foundation | Protection against ischemia and reperfusion injury |
| ATE406908T1 (de) * | 2000-10-20 | 2008-09-15 | Hamburger Stiftung Zur Foerder | Oxidierte proteine und deren biologische und therapeutische aktivität sowie diagnostische verwendung über die hemmung der interaktion zwischen oxidierten proteinen und cd36 |
| DE10051983A1 (de) * | 2000-10-20 | 2002-06-13 | Beate Kehrel | Inhibierung der pathogenen Wirkung oxidierter Proteine |
| JP2004525955A (ja) | 2001-04-05 | 2004-08-26 | コッラジェネックス ファーマシューチカルス インコーポレイテッド | テトラサイクリン化合物およびテトラサイクリン誘導体の制御された伝達 |
| US20070015146A1 (en) | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
| AU2002360460A1 (en) * | 2001-12-03 | 2003-06-17 | Nuvelo, Inc. | Methods and materials relating to novel polypeptides and polynucleotides |
| JP4346870B2 (ja) * | 2002-07-05 | 2009-10-21 | キッコーマン株式会社 | 血糖値上昇抑制用組成物 |
| US7785567B2 (en) * | 2002-08-23 | 2010-08-31 | Valorisation-Recherche, Société en Commandite | Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia |
| PT1599216E (pt) * | 2003-02-04 | 2013-12-17 | Cornell Res Foundation Inc | Métodos de prevenção da transição de permeabilidade mitocondrial |
| US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
| DK2604285T3 (en) * | 2003-05-01 | 2014-12-01 | Cornell Res Foundation Inc | Method and carrier complex for delivering molecules to cells |
| KR20060026011A (ko) | 2003-05-09 | 2006-03-22 | 노보 노르디스크 에이/에스 | 비만 치료용 펩티드 |
| US20050012597A1 (en) | 2003-07-02 | 2005-01-20 | Anderson Peter Traneus | Wireless electromagnetic tracking system using a nonlinear passive transponder |
| WO2005032481A2 (en) * | 2003-09-30 | 2005-04-14 | Scios Inc. | Quinazoline derivatives as medicaments |
| EP1529533A1 (en) * | 2003-11-06 | 2005-05-11 | Sahltech I Göteborg AB | Use of GH secretagogues in hypoxic-ischemic brain injury |
| CN1913774A (zh) * | 2003-12-12 | 2007-02-14 | 独立行政法人科学技术振兴机构 | 表达MEGSIN/RAGE/iNOS的疾病模型动物及借助于该动物评估化合物的方法 |
| CA2971931C (en) * | 2004-01-23 | 2019-01-08 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| US20050272101A1 (en) | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| US8157123B2 (en) * | 2005-02-23 | 2012-04-17 | The Glad Products Company | Container |
| EP3725324A1 (en) | 2005-09-16 | 2020-10-21 | Cornell Research Foundation, Inc. | Aromatic-cationic peptide for use in a method for reducing cd36 expression |
| US20070259377A1 (en) * | 2005-10-11 | 2007-11-08 | Mickey Urdea | Diabetes-associated markers and methods of use thereof |
| US20080027082A1 (en) | 2006-06-19 | 2008-01-31 | Berthold Hocher | Use of adenosine a1 antagonists in radiocontrast media induced nephropathy |
| DK2252312T3 (da) * | 2008-02-07 | 2014-06-16 | Univ Cornell | Fremgangsmåder til forebyggelse eller behandling af insulinresistens |
| CN101951936A (zh) | 2008-02-26 | 2011-01-19 | 康奈尔大学 | 用于防止和治疗急性肾损伤的方法 |
| JP2012181082A (ja) * | 2011-03-01 | 2012-09-20 | Tokyo Electric Power Co Inc:The | 仕切弁の分解点検補助装置およびその案内治具、並びに仕切弁の分解点検方法 |
| CN202756379U (zh) | 2012-07-13 | 2013-02-27 | 滨中元川金属制品（昆山）有限公司 | 一种自攻牙螺丝 |
-
2006
- 2006-09-18 EP EP20167024.7A patent/EP3725324A1/en active Pending
- 2006-09-18 US US11/532,764 patent/US7541340B2/en active Active
- 2006-09-18 CA CA2947330A patent/CA2947330C/en active Active
- 2006-09-18 CA CA2947343A patent/CA2947343C/en active Active
- 2006-09-18 CA CA2947335A patent/CA2947335A1/en not_active Abandoned
- 2006-09-18 CN CN2006800400192A patent/CN101296704B/zh active Active
- 2006-09-18 CA CA2947341A patent/CA2947341C/en active Active
- 2006-09-18 CA CA2947328A patent/CA2947328C/en active Active
- 2006-09-18 KR KR1020157000640A patent/KR101621493B1/ko active Active
- 2006-09-18 DK DK06814864.2T patent/DK1931369T3/en active
- 2006-09-18 JP JP2008531412A patent/JP5416971B2/ja active Active
- 2006-09-18 EP EP06814864.2A patent/EP1931369B1/en active Active
- 2006-09-18 CN CN201210028972.2A patent/CN102552874B/zh active Active
- 2006-09-18 EP EP17172250.7A patent/EP3260127B1/en active Active
- 2006-09-18 CA CA2622911A patent/CA2622911C/en active Active
- 2006-09-18 KR KR1020157000639A patent/KR20150013353A/ko not_active Ceased
- 2006-09-18 CN CN201510142734.8A patent/CN104788540B/zh active Active
- 2006-09-18 EP EP16176957.5A patent/EP3095454A1/en not_active Withdrawn
- 2006-09-18 CA CA2947340A patent/CA2947340C/en active Active
- 2006-09-18 KR KR1020147021832A patent/KR20140106761A/ko not_active Ceased
- 2006-09-18 WO PCT/US2006/036291 patent/WO2007035640A2/en not_active Ceased
- 2006-09-18 CN CN201410509385.4A patent/CN104324360A/zh active Pending
- 2006-09-18 CN CN201310627156.8A patent/CN103784937B/zh active Active
- 2006-09-18 EP EP19160103.8A patent/EP3549594A1/en not_active Withdrawn
- 2006-09-18 KR KR1020087009150A patent/KR101426070B1/ko active Active
- 2006-09-18 CN CN201610884213.4A patent/CN107412723A/zh active Pending
- 2006-09-18 CA CA2947333A patent/CA2947333A1/en not_active Abandoned
- 2006-09-18 KR KR1020147007878A patent/KR20140042940A/ko not_active Ceased
- 2006-09-18 AU AU2006292352A patent/AU2006292352B2/en active Active
-
2009
- 2009-05-01 US US12/434,216 patent/US7811987B2/en active Active
-
2010
- 2010-08-04 US US12/850,079 patent/US8603971B2/en active Active
-
2012
- 2012-08-17 JP JP2012181082A patent/JP5805596B2/ja active Active
-
2013
- 2013-01-17 JP JP2013006199A patent/JP5809649B2/ja active Active
- 2013-11-08 US US14/075,686 patent/US9150614B2/en active Active
-
2014
- 2014-05-22 US US14/285,226 patent/US20140256620A1/en not_active Abandoned
-
2015
- 2015-06-08 JP JP2015115856A patent/JP6157539B2/ja active Active
- 2015-08-04 HK HK15107494.9A patent/HK1206971A1/xx unknown
- 2015-08-07 JP JP2015156656A patent/JP6175107B2/ja active Active
-
2016
- 2016-05-09 KR KR1020160056491A patent/KR20160056863A/ko not_active Ceased
- 2016-05-10 KR KR1020160057030A patent/KR20160057372A/ko not_active Ceased
- 2016-12-05 US US15/369,281 patent/US20170305967A1/en not_active Abandoned
-
2017
- 2017-01-05 JP JP2017000444A patent/JP6385476B2/ja active Active
- 2017-09-08 KR KR1020170115440A patent/KR101999756B1/ko active Active
-
2018
- 2018-09-24 US US16/140,325 patent/US20190248833A1/en not_active Abandoned
-
2019
- 2019-07-08 KR KR1020190082102A patent/KR20190084025A/ko not_active Ceased
-
2020
- 2020-04-02 US US16/838,290 patent/US11447523B2/en active Active
-
2022
- 2022-08-03 US US17/880,271 patent/US20230212220A1/en not_active Abandoned
-
2025
- 2025-01-15 US US19/022,723 patent/US20250263433A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017066161A5 (cg-RX-API-DMAC7.html) | ||
| JP2015164953A5 (cg-RX-API-DMAC7.html) | ||
| JP2016053040A5 (cg-RX-API-DMAC7.html) | ||
| JP2010222367A5 (cg-RX-API-DMAC7.html) | ||
| JP2015057451A5 (cg-RX-API-DMAC7.html) | ||
| PH12015501623A1 (en) | Glyco-modified atrial natriuretic peptide | |
| NZ707640A (en) | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| MX2022008277A (es) | Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas. | |
| PE20160012A1 (es) | Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral | |
| IL307992A (en) | Parasitic formulations containing isoxazoline and methods for treating blepharitis | |
| MX394496B (es) | Administracion de metabolitos de berberina | |
| MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
| MX393782B (es) | Formulaciones a largo plazo | |
| CO7151496A2 (es) | Agentes terapeúticos para administración subcutánea optimizados | |
| CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
| PE20190210A1 (es) | Aplicaciones de carrimicina en la infeccion por micobacterium tuberculosis resistente | |
| CL2015000891A1 (es) | Compuestos derivados de fenil-etinilo, moduladores de la actividad del receptor mglur5; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de la ansiedad, dolor, depresion,entre otras. | |
| CL2013003700A1 (es) | Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico. | |
| WO2016030899A8 (en) | Methods of treating amyotrophic lateral scleroses | |
| MX2016007682A (es) | Composicion farmaceutica que comprende ivabradina amorfa. | |
| CL2008000607A1 (es) | Composicion analgesica en forma de dosificacion parenteral unitaria o en una forma de dosificacion unitaria adecuada para una administracion por la mucosa o la dermis que comprende buprenorfina y nalmefeno, util para el tratamiento del dolor. | |
| JP2007119497A5 (cg-RX-API-DMAC7.html) | ||
| EA201071138A1 (ru) | Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона | |
| PE20151300A1 (es) | Composicion antifungica topica para el tratamiento de onicomicosis |